View Older Stories View More Recent Stories

Jul 15, 2021 08:02AM Cleveland Clinic Bans Biogen's (BIIB) Aduhelm, Will Others Follow Suit?

Jul 14, 2021 03:33PM Teladoc's (TDOC) Solo Platform's Integration with MS Teams Creates a Seamless Enterprise Solution

Jul 14, 2021 11:56AM AcelRX Pharmaceuticals (ACRX) is 'Making the Right Moves' with Recent Licensing Deals

Jul 13, 2021 03:37PM What To Expect Ahead Of Infinity Pharmaceuticals, Inc’s (INFI) 1L TNBC Data Update on July 27th?

Jul 13, 2021 12:46PM Newly Released FDA Briefing Docs Add Uncertainty Over Fibrogen's (FGEN) Roxadustat Approval

Jul 13, 2021 09:43AM What to Expect of Biogen's (BIIB) Aduhelm Review by Centers For Medicare and Medicaid Services

Jul 12, 2021 04:41PM What to Expect Ahead of AstraZeneca's (AZN) Roxadustat FDA Adcom on July 15?

Jul 12, 2021 01:59PM Establishment Labs (ESTA) CFO Departure Not to Overshadow Strong Growth

Jul 12, 2021 10:18AM Celldex Therapeutics (CLDX) Gains on CDX-0159 Update, Which Has Drug 'In the Driver's Seat'

Jul 12, 2021 07:42AM FDA Investigation Unlikely to Influence Biogen's (BIIB) Aduhelm Uptake - Analyst

Jul 9, 2021 04:15PM Analysts See Further Upside In (KURA), Following Novartis Collaboration

Jul 9, 2021 01:36PM Biogen (BIIB) Shares Down 4% As Head of FDA Calls for a Federal Investigation into Approval of Aduhelm

Jul 9, 2021 11:58AM Are Biopharma Stocks Poised for Q2 Beats?

Jul 8, 2021 08:32AM Biogen's (BIIB) Announces Updated ADUHELM Label, Analyst Expects No Material Change

Jul 7, 2021 11:36AM Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT

Jul 6, 2021 01:19PM Provention Bio (PRVB) Plunges Following CRL for Teplizumab in Type 1 Diabetes

View More Recent Stories View Older Stories